Idiopathic Hypersomnia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Conditions: Idiopathic Hypersomnia; Narcolepsy Without CataplexyInterventions: Drug: BTD-001; Drug: PlaceboSponsor: Balance TherapeuticsNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2015 Category: Research Source Type: clinical trials